Metabolic health during a randomized controlled lifestyle intervention in women with PCOS

Eur J Endocrinol. 2021 Nov 30;186(1):53-64. doi: 10.1530/EJE-21-0669.

Abstract

Context: Women with polycystic ovary syndrome (PCOS) have an increased risk of metabolic syndrome (MetS). Both PCOS and MetS are associated with excess weight.

Objective: To examine the effect of a three-component lifestyle intervention (LSI) with or without short message service (SMS+ or SMS-, respectively) on the prevalence and severity of MetS and metabolic parameters, compared to care as usual (CAU).

Design: Randomized controlled trial.

Methods: Women diagnosed with PCOS and a BMI >25 kg/m2 (n = 183) were either assigned to a 1-year three-component (cognitive behavioural therapy, diet, and exercise) LSI, with or without SMS support, or to CAU which provided weight-loss advice only. Main outcome measures included changes in the prevalence of MetS, the continuous MetS severity z-score (cMetS z-score), metabolic parameters, and the impact of weight loss.

Results: After 1 year, the decrease in the cMetS z-score was greater in the SMS+ group than the CAU group (-0.39, P = 0.015). The prevalence of MetS changed with -21.6% (P = 0.037), -16.5% (P = 0.190), and +7.0% (P = 0.509) in both LSI groups and CAU group, respectively. A post hoc analysis for both LSI groups combined vs CAU resulted in a MetS difference of -25.9% (P = 0.046). Moreover, weight loss per se resulted in significantly favourable effects on all metabolic parameters.

Conclusions: This three-component LSI was more successful in improving metabolic health compared to CAU. Therefore, we recommend this intervention to women with PCOS and excess weight, provided that a clinically relevant weight loss is being pursued.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Behavior Therapy / methods
  • Combined Modality Therapy
  • Diet Therapy
  • Exercise Therapy
  • Female
  • Humans
  • Life Style
  • Metabolic Syndrome / epidemiology
  • Metabolic Syndrome / etiology
  • Metabolic Syndrome / prevention & control*
  • Monitoring, Physiologic / instrumentation
  • Monitoring, Physiologic / methods
  • Netherlands / epidemiology
  • Obesity / complications
  • Obesity / epidemiology
  • Obesity / metabolism
  • Obesity / therapy
  • Overweight / complications
  • Overweight / epidemiology
  • Overweight / metabolism
  • Overweight / therapy
  • Patient Education as Topic / methods
  • Polycystic Ovary Syndrome / complications
  • Polycystic Ovary Syndrome / epidemiology
  • Polycystic Ovary Syndrome / metabolism*
  • Polycystic Ovary Syndrome / therapy*
  • Prevalence
  • Smartphone
  • Treatment Outcome